ALZA

ALZA Corporation

Application Filed: 2000-11-01
Trademark Application Details
Trademark Logo ALZA

Mark For: ALZA® trademark registration is intended to cover the categories of pharmaceuticals namely, pilocarpine for treating glaucoma, progesterone for contraception, oxybutynin for urinary and bladder conditions, methylphenidate for treatment of attention deficit disorder, systemic alkalizers, amifostine for treating toxic effects of chemotherapy, pentosan polysulfate sodium for treatment of interstitial cystitis, clotrimazole for treatment of fungal infections, and tetracycline for treatment of bacterial infections. [all]

Status

2022-09-23 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.


Research OneLook Acronym Finder
Serial Number76159119
Registration Number2619940
Mark Literal ElementsALZA
Mark Drawing Type5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationSCANNING ON DEMAND 2007-12-06
Basis1(a)
Class StatusSECTION 8 - CANCEL
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseYes
Current UseYes
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Cancellation Code2
Attorney NameRICHARD F BIRIBAUER
Law Office AssignedM60
Employee NameDUMONT, GREGORY T

Timeline

1974-00-00Date of First Use
1974-09-23Date of First Use
1974-09-23Date of Use In Commerce
2000-11-01Application Filed
2002-06-25Published
2002-06-25Published for Opposition
2002-09-17Trademark Registered
2007-12-06Location: SCANNING ON DEMAND
2009-05-16Cancelled
2009-05-16Status: Dead/Cancelled
2009-05-16Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: ALZA Corporation
Address1900 Charleston Road P.O. Box 7210 Mountain View, CALIFORNIA UNITED STATES 940397210
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

ApplicationIMAGE/TIFF2000-11-01
DrawingIMAGE/TIFF2000-11-01
SpecimenIMAGE/TIFF2000-11-01
Paper Correspondence Incoming2002-01-24
Registration Certificate2002-09-17
Registration CertificateIMAGE/TIFF2002-09-17
File Jacket2007-11-30
Specimen2007-11-30
Unclassified2007-11-30

Attorney of Record

RICHARD F BIRIBAUER
ALZA CORPORATION
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NEW JERSEY 08933-7001

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals namely, pilocarpine for treating glaucoma, progesterone for contraception, oxybutynin for urinary and bladder conditions, methylphenidate for treatment of attention deficit disorder, systemic alkalizers, amifostine for treating toxic effects of chemotherapy, pentosan polysulfate sodium for treatment of interstitial cystitis, clotrimazole for treatment of fungal infections, and tetracycline for treatment of bacterial infections. FIRST USE: 19740000. FIRST USE IN COMMERCE: 19740000(CANCELLED)
IC 010. US 026 039 044. G & S: medical devices namely, osmotic pumps, intrauterine devices, implantable periodontal fibers, implant implanting equipment and occular inserts. FIRST USE: 19740000. FIRST USE IN COMMERCE: 19740000

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:10
U.S. Codes:026,039,044
Type CodeType
GS0051Pharmaceuticals namely, pilocarpine for treating glaucoma, progesterone for contraception, oxybutynin for urinary and bladder conditions, methylphenidate for treatment of attention deficit disorder, systemic alkalizers, amifostine for treating toxic effects of chemotherapy, pentosan polysulfate sodium for treatment of interstitial cystitis, clotrimazole for treatment of fungal infections, and tetracycline for treatment of bacterial infections

Trademark Filing History

DescriptionDateProceeding Number
CANCELLED SEC. 8 (6-YR)2009-05-16
CASE FILE IN TICRS2007-12-06
REGISTERED-PRINCIPAL REGISTER2002-09-17
PUBLISHED FOR OPPOSITION2002-06-25
NOTICE OF PUBLICATION2002-06-05
APPROVED FOR PUB - PRINCIPAL REGISTER2002-04-19
CORRESPONDENCE RECEIVED IN LAW OFFICE2002-01-24
NON-FINAL ACTION MAILED2001-07-25
ASSIGNED TO EXAMINER2001-05-2278485

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed